Yasemin Yozgat Byrne

Yasemin Yozgat Byrne

Auto-generated profile, based on publicly available information

Yasemin Yozgat Byrne

Research Institute for Health Sciences and Technologies (SABITA), Cancer Research Center, Istanbul Medipol University, Beykoz, Istanbul 34810, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2019 in TURKISH JOURNAL OF BIOLOGY
Verified
Journal Article
Open access
ASArzu Sakul
Arzu Sakul
MOMehmet Ozansoy
Mehmet Ozansoy
BEBirsen Elibol
Birsen Elibol
SASule Ayla
Sule Ayla
MGMehmet Yalçın Günal
Mehmet Yalçın Günal
ÜKÜlkan Kiliç
Ülkan Kiliç
The clinical use of cisplatin, which is a first-line anticancer agent, is highly restricted due to its adverse effects on kidneys that lead to nephrotoxicity. Therefore, some potential reno-protective substances have been used in combination with cisplatin to cope with nephrotoxicity. Due to its high antitumor activity and oxygen-carrying capacity, we investigated the molecular effects of squalene against cisplatin-induced oxidative stress and kidney damage in mice. Single dose of cisplatin (7 mg/kg) was given to male Balb/c mice. Squalene (100 mg/kg/day) was administered orogastrically to mice for 10 days. Following sacrification, molecular alterations were investigated as analysis of the levels of oxidative stress index (OSI), inflammatory cytokines and cell survival-related proteins in addition to histopathological examinations in mice kidney tissue. The level OSI and Interferon-gamma (IFN-γ) decreased in the cisplatin and squalene cotreated mice compared to cisplatin-treated mice. Squalene treatment also increased the activation of protein kinase B (AKT). Furthermore, cisplatin-induced inactivation of mammalian target of rapamycin (mTOR) and histopathological damages were reversed by squalene. It may be suggested that squalene ameliorated the cisplatin-induced histopathological damages in the kidney through activation of AKT/mTOR signaling pathway by regulating the balance of the redox system due to its antioxidative effect.

1 July 2024 in Pathology - Research and Practice
Verified
Journal Article
Closed access
SASule Ayla
Sule Ayla
EKEmre Karakoc
Emre Karakoc
YBYasemin Yozgat Byrne
Yasemin Yozgat Byrne
CPCuneyd Parlayan
Cuneyd Parlayan
IKIlknur Keskin
Ilknur Keskin
GOGulperi Oktem
Gulperi Oktem